Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study (Q33559116)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study |
scientific article |
Statements
1 reference
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study (English)
1 reference
Susan M Blaney
1 reference
John M Maris
1 reference
Yael P Mossé
1 reference
Emily Lipsitz
1 reference
Elizabeth Fox
1 reference
David T Teachey
1 reference
Brenda Weigel
1 reference
Peter C Adamson
1 reference
Mark A Ingle
1 reference
Charlotte H Ahern
1 reference
17 September 2012
1 reference
1 reference
18
1 reference
21
1 reference
6058-6064
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference